Ubiquitination/ Proteasome


Once the substrate protein is labeled, proteasome will bind to a polyubiquitin chain, allowing the degradation of the labeled protein. The polyubiquitinated target protein is then recognized and degraded by the 26S proteasome. Deubiquitinating enzymes (DUBs) reverse the process of ubiquitination by removing ubiquitin from its substrate protein. Dysregulation of the ubiquitin-proteasome system has been linked to cancer, diabetes, cardiovascular and neurodegenerative diseases etc.
-
A1903 E 64d10 CitationSummary: Cysteine protease inhibitor -
A4443 Gliotoxin1 CitationTarget: 20S proteasomal chymotrypsin|Geranylgeranyltransferase I|FarnesyltransferaseSummary: 20S proteasome inhibitor -
A4429 Vialinin ATarget: Deubiquitinating enzymes (DUBs)|IL Receptors|CCL2Summary: USP/isopeptidase T (IsoT)/UCH-L1 DUB inhibitor -
A8250 LY 29400270 CitationTarget: PI3KSummary: Potent PI3K inhibitor -
A2845 Omeprazole2 CitationSummary: H+,K+-ATPase inhibitor -
A2324 Dexamethasone (DHAP)12 CitationTarget: interleukin receptorSummary: Glucocorticoidan; anti-inflammatory -
A8323 WP11301 CitationSummary: Deubiquitinase (DUB) inhibitor, Cell permeable -
A8353 3-Methyladenine47 CitationTarget: PI3KSummary: Class III PI3K inhibitor -
A8484 NimodipineSummary: Calcium Channel inhibitor & Autophagy activator -
A8628 Chloroquine diphosphate17 CitationTarget: AutophagySummary: Antimalarial drug, TLR7 and TLR9 inhibitor
